A new study has investigated how different medications and therapies compare with placebos in treating ADHD symptoms. Attention deficit hyperactivity disorder, or ADHD, was long thought to be a ...

Granules India receives USFDA tentative approval for generic amphetamine extended-release tablets for ADHD treatment.

ADHD is a disorder with symptoms of inattention such as distractibility and disorganization. It can also include hyperactivity and impulsivity in some but not all individuals. ADHD begins in childhood ...

This graph visualizes how the trials included in the meta-analysis compared the effectiveness of different treatment strategies. The width of the lines connecting each treatment reflects the number of ...

Task paralysis is believed to be related to sensory overload, and generally looks like “over-analyzing, the inability to get ...

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental condition that causes hyperactivity and impulsivity in children and adults. If left untreated ...

"We've had to work on her study skills, but there's no way she'd go back to taking the drugs." While doctors don't endorse patients with /topics/Attention_Deficit_Disorders" ...

Feel like your brain is always on overdrive? Struggling to stay focused at work, forgetting things, jumping from one task to the next, or feeling like no matter how hard you try, you're always falling ...

Granules said on December 22, 2025 it had received a tentative approval for the Amphetamine Extended-Release Orally ...

Are you or your loved one struggling with the overwhelming effects of trauma, PTSD, or substance abuse? Perhaps your child is facing challenges with ADHD, autism spectrum disorders, or behavioral ...

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental condition that affects how the brain regulates ...

Shanghai Ark Biopharmaceutical Co., Ltd. ('ArkBio') today announced that China's National Medical Products Administration ...